Clinical Trials - Cardiovascular Disease and HIV
A5332: Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
Study Location: BaltimoreIndia
Eligibility: HIV infected men and women between the ages of 40 and 75 On HIV medications for at least 6 months CD4 cell count greater...
A5314: Effect of LDMTX on Inflammation in HIV-infected Individuals
Study Location: Baltimore
Eligibility: HIV-infected men and women ≥40 years old, who have been virologically suppressed on continuous antiretroviral therapy for at...